Tsunashima, Ryo
Naoi, Yasuto http://orcid.org/0000-0002-6090-0137
Shimazu, Kenzo
Kagara, Naofumi
Shimoda, Masashi
Tanei, Tomonori
Miyake, Tomohiro
Kim, Seung Jin
Noguchi, Shinzaburo
Article History
Received: 6 March 2018
Accepted: 2 May 2018
First Online: 4 May 2018
Compliance with ethical standards
:
: Professor Noguchi has been an advisor for Taiho, AstraZeneca and Novartis, and has received research funding for other studies from Sysmex, AstraZeneca, Novartis, Chugai, Daiichi-Sankyo, Kyowa-Kirin, Takeda, Pfizer, Ono, Taiho, and Eisai, and honoraria from AstraZeneca, Novartis, Pfizer, Chugai, Takeda, Sysmex, Nippon Kayaku, Ono. Dr. Kim has received honoraria from AstraZeneca. Dr. Shimazu has received honoraria from AstraZeneca and Chugai. Dr. Naoi has received research funding from Sysmex and AstraZeneca for other studies.
: This study complies with the current relevant laws of and guidelines for Japan.